To determine the association of the frailty phenotype with subsequent healthcare costs and utilization. DESIGN: Prospective cohort study (Study of Osteoporotic Fractures (SOF) 
O lder age and multiple chronic medical conditions (multimorbidity) in Medicare beneficiaries in the United States are associated with higher healthcare costs and greater utilization.
1,2 However, there is considerable individual variability in healthcare costs and utilization in older populations, and multimorbidity explains only a modest proportion of the variance in total healthcare costs. 3 Hence, more accurate identification of older adults who are likely to require intense, costly care is needed.
Frailty, a geriatric syndrome of low reserves and poor resistance to stressors resulting from cumulative decline in multiple physiological systems, has been associated with risk of adverse health outcomes. In an attempt to operationalize the syndrome of frailty, Fried and colleagues, 4 using data from the Cardiovascular Health Study (CHS), proposed a phenotype of frailty in which 3 or more of the following 5 components were present: shrinking, weakness, poor energy, slowness, and low activity level. Although operational definitions of frailty vary, the validity of the CHS frailty phenotype [5] [6] [7] for prediction of risk of adverse clinical outcomes has been confirmed in several cohorts.
A cross-sectional study of older German adults 8 reported that frailty as defined using a modified CHS phenotype 9 was associated with higher healthcare costs but relied on participant recall to derive estimates of costs. Most studies examining the association between the frailty phenotype and healthcare utilization focused on past hospitalization 4, 10 or enrolled selected populations. 11, 12 To examine the association of the frailty phenotype with subsequent total direct healthcare costs and utilization, we used a unique longitudinal dataset comprising 2,150 women (mean age 80.2) participating in the Year 10 (Y10) examination of the Study of Osteoporotic Fractures (SOF) linked to their Medicare claims data.
METHODS

Study Population and Linkage to Inpatient Claims
We studied participants enrolled in SOF, a prospective cohort study of community-dwelling women. From 1986 to 1988, 9,704 Caucasian women aged 65 and older who were able to walk unassisted were recruited for participation from 4 geographic areas of the United States. 13 Linkage of cohort data and Medicare claims was successful for 8,604 women (92.3% of surviving participants) as of January 1, 1991, the earliest date for which outpatient Medicare claims are available. 14, 15 Five thousand fortytwo women from the original cohort completed a Y10 examination (clinic or home) that included assessment of frailty phenotype (Supplementary Figure S1) . Of these women, the analytic cohort included 2,150 women who had data for the frailty phenotype and were also enrolled in the Medicare fee-for-service (FFS) program (Parts A and B but not Part C, Medicare Advantage) from 12 months before until 12 months after the Y10 examination (or until death within this period).
Measurements
Participants were asked about education and smoking status. Physical activity (expressed as a weighted score of kcal/wk) was assessed using a modified version of the Harvard Alumni Questionnaire. 16 Depressive symptoms were evaluated using the 15-item Geriatric Depression Scale 17 (which includes the question "Do you feel full of energy?"). Cognitive function was assessed using a modified version of the Mini-Mental State Examination 18 with a maximum score of 26. Tests of physical performance included grip strength (handheld dynamometer) and usual gait speed (average speed at usual pace in 2 trials over a 6-m course). Body weight and height were measured, and body mass index was calculated. Women were asked whether they had difficulty performing any of 5 instrumental activities of daily living (IADLs). 19 Participant multimorbidity burden was ascertained according to a count of Elixhauser conditions, 20 a sum of indicator variables for 31 specific medical conditions derived from International Classification of Diseases, Ninth Revision, codes in Medicare inpatient and outpatient claims during the 12 months before the Y10 SOF examination. Multimorbidity was categorized as none (0-1 conditions), mild (2-3 conditions), or moderate or worse (4 conditions).
Frailty Phenotype
The frailty phenotype was operationalized using criteria similar to those of the CHS frailty phenotype: 4 Shrinking: weight loss of 5% or more between the Y8 and Y10 examinations (mean 2.3 years between examinations)
Weakness: Y10 grip strength in the lowest quintile stratified according to body mass index (quartiles).
Poor energy: answered "no" to the question, "Do you feel full of energy?" on the Y10 Geriatric Depression Scale.
Slowness: Y10 gait speed in the lowest quintile stratified according to standing height (median).
Low physical activity: Y10 weighted score of kilocalories expended per week in the lowest quintile.
Women were robust if they had none of the components, intermediate stage (prefrail) if they had 1 or 2 components, and frail if they had 3 or more components.
Outcome Measures
The primary outcome was total direct healthcare costs for the 12 months after the Y10 examination. We used 12-month cost data for everyone, including the 44 women (2.0%) who died during this period. Total costs were calculated as the sum of costs for acute hospital stays, skilled nursing facility (SNF) stays paid under Medicare part A, inpatient rehabilitation facility (IRF) stays, outpatient care, and home health care for that time period. Acute hospital stays, SNF stays, and IRF stays were identified in the Medical Provider Analysis and Review file. Standardized costs for acute, short hospital stays, SNF stays, and IRF stays were estimated using a previously published, validated method. 15, 21 Costs for outpatient utilization and home healthcare utilization were based on the allowable charges for these services in the Carrier, Outpatient, and Home Health Care Medicare claims files. 22 The costs of all units of utilization were adjusted for healthcare cost inflation to U.S. 2014 dollars. 15 
Statistical Analysis
Generalized linear models (GLMs) were used to estimate the association between the Y10 frailty phenotype and mean total direct healthcare costs over the subsequent 12 months. Gamma distributions with log links were chosen based on Modified Park 23 and Pregibon link tests. 24 GLMs (gamma distributions, log links) were also used to analyze the association between the frailty phenotype and mean outpatient costs. Logistic models were used to estimate associations of the frailty phenotype with risks of 1 or more hospitalizations and 1 or more SNF stays. Robust women were the reference group. In addition, GLMs (gamma distributions, log links) were used to determine the association between each frailty component and subsequent total healthcare costs. Base models included age and study enrollment site. Potential confounders (Table 1) were screened for inclusion in multivariable models. Candidate covariates were included in multivariable models as confounders if they were associated with frailty phenotype; were independently related to total healthcare costs after adjustment for age, site, and frailty phenotype; and were not used to define a component of the frailty phenotype. Initially, multivariable models were further adjusted for multimorbidity and cognitive function. To determine whether greater selfreported functional limitations in intermediate stage and frail participants explained the association between the frailty phenotype and outcomes, IADL impairment was added to multivariable models.
RESULTS
The study cohort at Y10 included 2,150 communitydwelling women with a mean age6standard deviation of 80.264.4 (Table 1) . Of these women, 408 (19.0%) were frail, 1,188 (55.3%) were intermediate stage, and 554 (25.8%) were robust. One thousand two hundred eightyeight women (59.9%) had at least mild multimorbidity, and 512 (23.8%) had at least moderate multimorbidity. Frail women had a greater burden of coexisting medical conditions; at least moderate multimorbidity was noted in 12.5% of robust women, versus 43.6% of frail women. However, there was some variability in multimorbidity within each frailty phenotype category. For example, 21.3% of frail women had no multimorbidity, and 12.4% of robust women had at least moderate multimorbidity. Self-reported functional limitations also varied across the frailty phenotype; robust women had a mean of 0.2 IADL impairments, and frail women had 2.6.
In the overall cohort during the 12 months after Y10, median total healthcare costs (2014 U.S. dollars) were $1,892 (interquartile range (IQR) $677-6,533), and mean costs were $6,680612,466. Five hundred thirty-four women (24.8%) had at least 1 hospitalization, and 133 (6.2%) had at least 1 SNF stay.
Characteristics (including distribution of the frailty phenotype) of the 2,150 women in the analytical cohort were similar to those of the 2,892 SOF women attending Y10 examination who were excluded from analyses because they were not enrolled in a FFS plan (Supplementary Table S1 ).
Association of the Frailty Phenotype with Total and Outpatient Healthcare Costs
Mean and median total healthcare costs in the 12 months after Y10 exam were higher with greater degree of frailty 
Associations Between Individual Frailty Components and Total Healthcare Costs
Mean and median total healthcare costs were higher in women with a given frailty component than in those without that component (Supplementary Table S2 ). Shrinking (CR51.17, 95% CI51.01-1.35), poor energy (CR51.39, 95% CI51.24-1.56), slowness (CR51.37, 95% CI51.18-1.59), and low physical activity (CR51.44, 95% CI51.25-1.66) were each associated with higher mean total costs in models accounting for multimorbidity and cognition ( Table 4 ). The association between weakness and total costs was not statistically significant (CR51.12, 95% CI50.98-1.30). After further accounting for functional limitations, independent associations of poor energy (CR51.19, 95% CI51.06-1.34) and low physical activity (CR51.16, 95% CI51.00-1.35) with higher total costs remained.
DISCUSSION
In this cohort of older community-dwelling women, greater degree of frailty was associated with higher subsequent total direct healthcare costs. Nearly 1 in 5 frail women (and 1 in 10 intermediate stage women), compared with 1 in 25 robust women, were among the costliest 10% of individuals. Associations of the frailty phenotype with subsequent total costs and measures of healthcare burden in inpatient, postacute care, and outpatient sectors remained despite accounting for multimorbidity, functional limitations, and cognitive function.
Few previous studies have determined associations between the frailty phenotype and measures of healthcare burden in older community-dwelling populations. A study of older German adults 8 reported that greater degree of frailty (defined according to number of CHS frailty components) was associated with higher total healthcare costs even after accounting for multimorbidity. However, that study relied on participant recall of past healthcare use to derive cost estimates and did not consider the effect of self-reported function on the association. In addition, a cross-sectional survey of 1,284 French adults aged 65 and older (that made several adaptions to the CHS phenotype based on questionnaire contents) reported that pre-frailty and frailty had an incremental effect on ambulatory healthcare expenditures even after adjustment for selected self-reported medical conditions and functional limitations. 25 In contrast, our study used a prospective design; analyzed total healthcare costs and measures of costs or utilization in inpatient, postacute, and outpatient healthcare sectors; included a comprehensive assessment of prevalent multimorbidity; and defined the frailty phenotype using objective measures of weakness (grip strength) and slowness (gait speed). Similarly, retrospective design and incomplete adjustment for confounding limit most investigations examining the association between the frailty phenotype and hospitalization in adults not selected on the basis of disease status. In community-dwelling adults enrolled in CHS 4 and the National Health and Aging Trends Study, 10 the prevalence of self-reported hospitalization in the past year was higher with greater degree of frailty. A survey of European adults aged 50 and older 26 found that intermediate stage and frail individuals were more likely to report past hospitalization. Although greater frailty status may increase the risk of hospitalization, temporality of the association in these retrospective studies is uncertain because admission to an acute care hospital may also result in the development or progression of frailty. A longitudinal study of older community-dwelling adults residing in Boston 27 found that intermediate stage and frail individuals were more likely to report overnight hospitalizations and emergency department visits during an average follow-up of 10 months despite adjustment for demographic factors and cardiovascular risk factors. Our prospective study strengthens earlier findings with its longitudinal assessment of frailty and subsequent claims-based total healthcare costs and utilization and evaluation of these associations after accounting for comprehensively measured multimorbidity and functional limitations.
Individual frailty components of shrinking, poor energy, slowness, and low physical activity level were each associated with higher subsequent total healthcare costs in our study, even after adjustment for multimorbidity. After further consideration of functional limitations, associations with poor energy and low physical activity with healthcare expenditures remained. These findings are in general agreement with those of previous studies, 8, [28] [29] [30] [31] although prior investigations incompletely assessed whether consideration of multimorbidity and self-reported function alter these associations.
Our findings indicate that the frailty phenotype is a risk factor for high subsequent total healthcare costs above and beyond that is explained by burden of chronic medical conditions. Thus, assessment of the phenotype or selected individual components such as poor energy or slow gait may more accurately identify older community-dwelling individuals at higher risk of subsequent healthcare utilization, due to frailty itself or associated functional limitations. High-risk individuals would be candidates for targeted treatments aimed at reducing subsequent healthcare burden, including physical therapy, exercise programs, nutritional interventions, and enhanced social support services designed to ameliorate functional limitations. 32 In addition, in the event of a hospitalization, knowledge of the frailty phenotype or selected components previously assessed in the outpatient setting might improve decision-making of hospital-based clinicians regarding selection of individuals for discharge to a postacute care facility. 33 Further research regarding the feasibility and cost:benefit ratio of inclusion of assessment of the frailty phenotype or specific components in the outpatient clinical practice setting is needed.
This study has several strengths, including comprehensive participant characteristics available in cohort study data; linkage of participants to their Medicare claims to determine coexisting medical conditions and quantify subsequent healthcare expenditures and utilization; and consideration of traditional predictors of healthcare costs. This study also has limitations. The cohort comprised relatively well-functioning community-dwelling older white women. Results may not be generalizable to men, other racial or ethnic groups, or those with severe functional limitations, such as nursing home residents. However, community-dwelling older adults without overt disability may be most amenable to interventions designed to lower subsequent healthcare burden. Future studies are needed to replicate our findings in other populations. Cost and utilization data were limited to individuals enrolled in FFS plans, although characteristics of individuals who were excluded based on not participating in FFS were similar to characteristics of those included. Furthermore, evidence from the recent decade 34 (study data from 2004-2008) suggests that Medicare FFS and Medicare Advantage enrollees have similar healthcare expenditures. Our analyses expressed the frailty phenotype using criteria similar to those developed using CHS data, but other instruments have been developed to operationalize the construct of frailty. In particular, additional research is needed to standardize and cross-validate frailty instruments and determine whether results are consistent when the frailty phenotype is assessed using simpler instruments 35 suitable for use in the busy clinical practice setting.
In conclusion, the frailty phenotype was an independent determinant of subsequent healthcare expenditures and utilization, even after accounting for traditional indicators including multimorbidity and functional limitations. These results suggest that assessment of the frailty phenotype or selected components may improve identification of older community-dwelling adults likely to require more costly, intensive care to better facilitate targeting of interventions designed to reduce future healthcare burden. Author Contributions: Ensrud: study concept and design, acquisition of subjects and data, interpretation of data, preparation of manuscript. Kats, Schousboe, Taylor, Cawthon, Yaffe, Langsetmo: interpretation of data, critical review of manuscript. Hillier, Cummings, Cauley: study concept and design, acquisition of subjects and data, interpretation of data, critical review of manuscript.
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